Keith Wayne Ward - Dec 14, 2021 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
3
Date filed
12/16/2021, 05:43 PM
Next filing
Jan 9, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney.